European Parliament’s adoption of ‘Options for improving access to medicines’ procedure
ELC GROUP | March 02, 2017
The procedure places generic, biosimilar and value-added medicines at the heart of the debate on access to medicines. Specifically, the report calls for Member States to encourage competition from generic and biosimilar medicines by removing barriers and adopting uptake measures.